GlobeNewswire
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit
📈
AI Sentiment
Highly Positive
9/10
Tonix Pharmaceuticals Holding Corp. News
Latest updates and market news for TNXP
2 news
Jan 26 - Feb 1, 2026
Page 1
Zacks Small Cap Research
Zacks Small Cap Research Best Ideas for 2026
📈
AI Sentiment
Highly Positive
9/10
Share this news page